Impact of MDM2 single nucleotide polymorphism on tumor onset in head and neck squamous cell carcinoma. (Q54527845)

30 May 2018

title

Impact of MDM2 single nucleotide polymorphism on tumor onset in head and neck squamous cell carcinoma. (English)

1 reference

30 May 2018

single-nucleotide polymorphism

main subject

1 reference

Masashi Nakashima

1

1 reference

30 May 2018

Satoru Kondo

2

1 reference

30 May 2018

Yoshinori Shimizu

3

1 reference

30 May 2018

Naohiro Wakisaka

4

1 reference

30 May 2018

Shigeyuki Murono

5

1 reference

30 May 2018

Mitsuru Furukawa

6

1 reference

30 May 2018

Tomokazu Yoshizaki

7

1 reference

30 May 2018

language of work or name

English

0 references

publication date

1 July 2008

1 reference

30 May 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

Acta Oto-Laryngologica

1 reference

30 May 2018

volume

128

1 reference

30 May 2018

page(s)

808-813

1 reference

30 May 2018

issue

7

1 reference

30 May 2018

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The MDM2 gene amplification database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 SNP309 accelerates colorectal tumour formation in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Functions of the MDM2 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 promoter polymorphism is associated with both an increased susceptibility to gastric carcinoma and poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

A polymorphism in HDM2 (SNP309) associates with early onset in superficial tumors, TP53 mutations, and poor outcome in invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 SNP309 accelerates familial breast carcinogenesis independently of estrogen signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 SNP309 and SNP354 are not associated with lung cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 309T>G polymorphism and risk of lung cancer in a Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

p53 Codon 72 and MDM2 SNP309 Polymorphisms and Age of Colorectal Cancer Onset in Lynch Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00016480701724904

10.1080/00016480701724904

21 January 2018

Identifiers

DOI

1 reference

30 May 2018

PubMed ID

18568525

1 reference

30 May 2018